Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wunderink

Showing results (451-460 of 545) with videos related to

Pageof 55
Sort By:
Lancet (London, England)|September 12, 1998
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study GroupE Abraham, A Anzueto, G Gutierrez, et al.
Diagnostic Microbiology and Infectious Disease|January 19, 2024
(1-3)-ß-D-glucan for the diagnosis of Nocardia infection in solid organ transplant recipientsMargot Paumier, Julien Coussement, Marie Matignon, et al.
ERJ Open Research|July 7, 2018
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumoniaAntoni Torres, Michael S Niederman, Jean Chastre, et al.
CHEST Critical Care|March 30, 2026
Development of a Pilot Machine Learning Model to Predict Successful Short-Term Treatment Success in Critically Ill Patients With Community-Acquired PneumoniaMengou Zhu, Wan-Ting Liao, Alec Peltekian, et al.
The European Respiratory Journal|September 12, 2017
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT)Antoni Torres, Michael S Niederman, Jean Chastre, et al.
Journal of the Pediatric Infectious Diseases Society|February 4, 2017
Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired PneumoniaChris Stockmann, Krow Ampofo, Jarrett Killpack, et al.
Critical Care (London, England)|August 12, 2021
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trialJean-François Timsit, Jennifer A Huntington, Richard G Wunderink, et al.
Artificial Organs|October 25, 2021
Outcomes after extracorporeal membrane oxygenation support in COVID-19 and non-COVID-19 patientsChitaru Kurihara, Adwaiy Manerikar, Catherine Aiyuan Gao, et al.
Psychiatric Rehabilitation Journal|December 4, 2018
Functional recovery of individuals with serious mental illnesses: Development and testing of a new short instrument for routine outcome monitoringWilma Elisabeth Swildens, Ellen Visser, Michiel Bähler, et al.
Chest|June 3, 2018
In-Hospital Deaths Among Adults With Community-Acquired PneumoniaGrant W Waterer, Wesley H Self, D Mark Courtney, et al.
Pageof 55

Showing results (451-460 of 545) with videos related to

Sort By:
Pageof 55
Lancet (London, England)|September 12, 1998
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study GroupE Abraham, A Anzueto, G Gutierrez, et al.
Diagnostic Microbiology and Infectious Disease|January 19, 2024
(1-3)-ß-D-glucan for the diagnosis of Nocardia infection in solid organ transplant recipientsMargot Paumier, Julien Coussement, Marie Matignon, et al.
ERJ Open Research|July 7, 2018
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumoniaAntoni Torres, Michael S Niederman, Jean Chastre, et al.
CHEST Critical Care|March 30, 2026
Development of a Pilot Machine Learning Model to Predict Successful Short-Term Treatment Success in Critically Ill Patients With Community-Acquired PneumoniaMengou Zhu, Wan-Ting Liao, Alec Peltekian, et al.
The European Respiratory Journal|September 12, 2017
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT)Antoni Torres, Michael S Niederman, Jean Chastre, et al.
Journal of the Pediatric Infectious Diseases Society|February 4, 2017
Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired PneumoniaChris Stockmann, Krow Ampofo, Jarrett Killpack, et al.
Critical Care (London, England)|August 12, 2021
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trialJean-François Timsit, Jennifer A Huntington, Richard G Wunderink, et al.
Artificial Organs|October 25, 2021
Outcomes after extracorporeal membrane oxygenation support in COVID-19 and non-COVID-19 patientsChitaru Kurihara, Adwaiy Manerikar, Catherine Aiyuan Gao, et al.
Psychiatric Rehabilitation Journal|December 4, 2018
Functional recovery of individuals with serious mental illnesses: Development and testing of a new short instrument for routine outcome monitoringWilma Elisabeth Swildens, Ellen Visser, Michiel Bähler, et al.
Chest|June 3, 2018
In-Hospital Deaths Among Adults With Community-Acquired PneumoniaGrant W Waterer, Wesley H Self, D Mark Courtney, et al.
Pageof 55